David Helsel

Track

Insider profile

Currently holds a position at AngioDynamics Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President - Global Operations AngioDynamics Inc Dec. 1, 2017 -
Executive Vice President - Global Manufacturing Haemonetics Corp Jan. 1, 2013 - Jan. 1, 2016
Vice President - Global Manufacturing Haemonetics Corp March 5, 2012 - Jan. 1, 2013
David Helsel's trades of AngioDynamics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
52.86
Quantity 63,844 -2.7%
Value US$4,086,688
Transaction date
Sale
Price
87.80
Quantity 91,682 +41.4%
Value US$1,993,729
Transaction date
Sale
Price
319.05
Quantity 11,597 -42.1%
Value US$822,967
Transaction date
Sale
Price
27.97
Quantity 3,494 -11.7%
Value US$97,727
Transaction date
Sale
Price
23.93
Quantity 3,500 -15.5%
Value US$83,755
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-01 2023-01-31
S Sale
63,844 -2.7%
52.86
US$4,086,688 		63,844 -2.7% 52.86 US$4,086,688
2022-08-01 2022-07-29
S Sale
91,682 +41.4%
87.80
US$1,993,729 		91,682 +41.4% 87.80 US$1,993,729
2022-05-02 2022-04-28
S Sale
11,597 -42.1%
319.05
US$822,967 		11,597 -42.1% 319.05 US$822,967
2021-10-21 2021-10-20
S Sale
3,494 -11.7%
27.97
US$97,727 		3,494 -11.7% 27.97 US$97,727
2021-04-15 2021-04-14
S Sale
3,500 -15.5%
23.93
US$83,755 		3,500 -15.5% 23.93 US$83,755